DistressOther
PhaseBio Pharmaceuticals Inc acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
PhaseBio Pharmaceuticals Inc -> target · $12,947,099
Inventory ( Book ☐ Market ☐ Other ☒ (attach explanation)) $ 0 d Total current assets $ 2,591,989 e.
Open source record (SEC) ↗